Table 1 Baseline characteristics of study participants stratified by COVID-19 status

From: Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

  Non COVID-19 (n = 72) COVID-19 (n = 28)
Female (N, %) 59 (81.9) 25 (89.3)
Male (N, %) 13 (18.1) 3 (10.7)
Age group 18–35 years (N, %) 20 (27.7) 13 (46.4)
Age group 36–50 years (N, %) 28 (38.9) 9 (32.14)
Age group 51–65 years (N, %) 24 (33.3) 6 (21.4)
Respiratory symptoms (N, %)   17 (60.7)
Neurological symptoms (N, %)   21 (75.0)
  1. Notes: respiratory symptoms included cough and shortness of breath; neurological symptoms included headache and anosmia